Scientists have moved closer to developing a universal flu vaccine after using the 2009 pandemic as a natural experiment to study why some people seem to resist severe illness.
Researchers at Imperial College London asked volunteers to donate blood samples just as the swine flu pandemic was getting underway and report any symptoms they experienced over the next two flu seasons.
They found that those who avoided severe illness had more CD8 T cells, a type of virus-killing immune cell, in their blood at the start of the pandemic.
They believe a vaccine that stimulates the body to produce more of these cells could be effective at preventing flu viruses, including new strains that cross into humans from birds and pigs, from causing serious disease.
The findings are published in Nature Medicine.
Professor Ajit Lalvani from the National Heart and Lung Institute at Imperial College London, who led the study, said: "New strains of flu are continuously emerging, some of which are deadly, and so the Holy Grail is to create a universal vaccine that would be effective against all strains of flu."
Today's flu vaccines make the immune system produce antibodies that recognise structures on the surface of the virus to prevent infection with the most prevalent circulating strains. But they are usually one step behind as they have to be changed each year as new viruses with different surface structures evolve.
Previously, experimental models had suggested that T cells may protect against flu symptoms but until now this idea has not been tested in humans during a pandemic.
Professor Lalvani's team rapidly recruited 342 staff and students at Imperial to take part in their study in autumn 2009. The volunteers donated blood samples and were given nasal swabs. They were sent emails every three weeks asking them to fill in a survey about their health. If they experienced flu symptoms, they took a nasal swab and sent it back to the lab.
They found that those who fell more severely ill with flu had fewer CD8 T cells in their blood, and those who caught flu but had no symptoms or only mild symptoms had more of these cells.
Professor Lalvani said, "The immune system produces these CD8 T cells in response to usual seasonal flu. Unlike antibodies, they target the core of the virus, which doesn't change, even in new pandemic strains. The 2009 pandemic provided a unique natural experiment to test whether T cells could recognise, and protect us against, new strains that we haven't encountered before and to which we lack antibodies.
"Our findings suggest that by making the body produce more of this specific type of CD8 T cell, you can protect people against symptomatic illness. This provides the blueprint for developing a universal flu vaccine.
"We already know how to stimulate the immune system to make CD8 T cells by vaccination. Now that we know these T cells may protect, we can design a vaccine to prevent people getting symptoms and transmitting infection to others. This could curb seasonal flu annually and protect people against future pandemics."
Explore further: Universal flu vaccine may be a step closer
More information: S Sridhar et al. 'Cellular immune correlates of protection against symptomatic pandemic influenza.' Nature Medicine 2013. dx.doi.org/10.1038/nm.3350
Medical Xpress on facebook
Related Stories
Universal flu vaccine may be a step closer
Aug 16, 2013
(Medical Xpress)—A new study in the US suggests that boosting a certain group of antibodies could help to create a universal vaccine for influenza.
Vaccination may make flu worse if exposed to a second strain
Aug 30, 2013
(Medical Xpress)—A new study in the U.S. has shown that pigs vaccinated against one strain of influenza were worse off if subsequently infected by a related strain of the virus.
Some flu vaccines promise a little more protection
Sep 02, 2013
It's time to get your flu vaccine, and this fall some brands promise a little extra protection.
Bird flu mutation study offers vaccine clue
Apr 08, 2013
(Medical Xpress)—Scientists have described small genetic changes that enable the H5N1 bird flu virus to replicate more easily in the noses of mammals.
Take kids to get their flu shots early, experts say
Sep 02, 2013
(HealthDay)—As soon as the updated seasonal flu vaccine becomes available, parents should bring children aged 6 months and older to get vaccinated, according to an updated policy statement from the American ...
Recommended for you
Prostacyclin analogs and PDE 5 inhibitors synergistically stimulate ATP release from human RBCs
Sep 20, 2013
Researchers at Saint Louis University School of Medicine have discovered a novel interaction between prostacyclin (PGI2) analogs and phosphodiesterase 5 (PDE5) inhibitors, two groups of drugs used in the treatment of pulmonary ...
Final piece found in puzzle of brain circuitry controlling fertility
Sep 20, 2013
In a landmark discovery, the final piece in the puzzle of understanding how the brain circuitry vital to normal fertility in humans and other mammals operates has been put together by researchers at New Zealand's University ...
New research on inherited herpesvirus may have implications for transplantation
Sep 20, 2013
Up to half a million people in Britain today may not know it, but in their genetic material they carry a particular form of herpesvirus 6 inherited from a parent.
Bacterial 'autopsy' could speed antibiotic discovery: study
Sep 20, 2013
(HealthDay)—Scientists say they've found a quicker way to analyze chemicals with bacteria-killing abilities in an advance they hope will speed the development of new antibiotics.
Opioid dependence plays role in chronic pain
Sep 19, 2013
The bodies of mammals, including humans, respond to injury by releasing endogenous opioids—compounds that mitigate acute pain. A team of researchers led by those at the University of Kentucky has uncovered groundbreaking ...
Right combination of sugars regulates brain development in worms
Sep 19, 2013
If the development of our nervous system is disturbed, we risk developing serious neurological diseases, impairing our sensory systems, movement control or cognitive functions. This is true for all organisms ...
User comments
© Medical Xpress 2011-2013, Phys.org network
Scientists have moved closer to developing a universal flu vaccine after using the 2009 pandemic as a natural experiment to study why some people seem to resist severe illness.
Researchers at Imperial College London asked volunteers to donate blood samples just as the swine flu pandemic was getting underway and report any symptoms they experienced over the next two flu seasons.
They found that those who avoided severe illness had more CD8 T cells, a type of virus-killing immune cell, in their blood at the start of the pandemic.
They believe a vaccine that stimulates the body to produce more of these cells could be effective at preventing flu viruses, including new strains that cross into humans from birds and pigs, from causing serious disease.
The findings are published in Nature Medicine.
Professor Ajit Lalvani from the National Heart and Lung Institute at Imperial College London, who led the study, said: "New strains of flu are continuously emerging, some of which are deadly, and so the Holy Grail is to create a universal vaccine that would be effective against all strains of flu."
Today's flu vaccines make the immune system produce antibodies that recognise structures on the surface of the virus to prevent infection with the most prevalent circulating strains. But they are usually one step behind as they have to be changed each year as new viruses with different surface structures evolve.
Previously, experimental models had suggested that T cells may protect against flu symptoms but until now this idea has not been tested in humans during a pandemic.
Professor Lalvani's team rapidly recruited 342 staff and students at Imperial to take part in their study in autumn 2009. The volunteers donated blood samples and were given nasal swabs. They were sent emails every three weeks asking them to fill in a survey about their health. If they experienced flu symptoms, they took a nasal swab and sent it back to the lab.
They found that those who fell more severely ill with flu had fewer CD8 T cells in their blood, and those who caught flu but had no symptoms or only mild symptoms had more of these cells.
Professor Lalvani said, "The immune system produces these CD8 T cells in response to usual seasonal flu. Unlike antibodies, they target the core of the virus, which doesn't change, even in new pandemic strains. The 2009 pandemic provided a unique natural experiment to test whether T cells could recognise, and protect us against, new strains that we haven't encountered before and to which we lack antibodies.
"Our findings suggest that by making the body produce more of this specific type of CD8 T cell, you can protect people against symptomatic illness. This provides the blueprint for developing a universal flu vaccine.
"We already know how to stimulate the immune system to make CD8 T cells by vaccination. Now that we know these T cells may protect, we can design a vaccine to prevent people getting symptoms and transmitting infection to others. This could curb seasonal flu annually and protect people against future pandemics."
Explore further: Universal flu vaccine may be a step closer
More information: S Sridhar et al. 'Cellular immune correlates of protection against symptomatic pandemic influenza.' Nature Medicine 2013. dx.doi.org/10.1038/nm.3350
Medical Xpress on facebook
Related Stories
Universal flu vaccine may be a step closer
Aug 16, 2013
(Medical Xpress)—A new study in the US suggests that boosting a certain group of antibodies could help to create a universal vaccine for influenza.
Vaccination may make flu worse if exposed to a second strain
Aug 30, 2013
(Medical Xpress)—A new study in the U.S. has shown that pigs vaccinated against one strain of influenza were worse off if subsequently infected by a related strain of the virus.
Some flu vaccines promise a little more protection
Sep 02, 2013
It's time to get your flu vaccine, and this fall some brands promise a little extra protection.
Bird flu mutation study offers vaccine clue
Apr 08, 2013
(Medical Xpress)—Scientists have described small genetic changes that enable the H5N1 bird flu virus to replicate more easily in the noses of mammals.
Take kids to get their flu shots early, experts say
Sep 02, 2013
(HealthDay)—As soon as the updated seasonal flu vaccine becomes available, parents should bring children aged 6 months and older to get vaccinated, according to an updated policy statement from the American ...
Recommended for you
Prostacyclin analogs and PDE 5 inhibitors synergistically stimulate ATP release from human RBCs
Sep 20, 2013
Researchers at Saint Louis University School of Medicine have discovered a novel interaction between prostacyclin (PGI2) analogs and phosphodiesterase 5 (PDE5) inhibitors, two groups of drugs used in the treatment of pulmonary ...
Final piece found in puzzle of brain circuitry controlling fertility
Sep 20, 2013
In a landmark discovery, the final piece in the puzzle of understanding how the brain circuitry vital to normal fertility in humans and other mammals operates has been put together by researchers at New Zealand's University ...
New research on inherited herpesvirus may have implications for transplantation
Sep 20, 2013
Up to half a million people in Britain today may not know it, but in their genetic material they carry a particular form of herpesvirus 6 inherited from a parent.
Bacterial 'autopsy' could speed antibiotic discovery: study
Sep 20, 2013
(HealthDay)—Scientists say they've found a quicker way to analyze chemicals with bacteria-killing abilities in an advance they hope will speed the development of new antibiotics.
Opioid dependence plays role in chronic pain
Sep 19, 2013
The bodies of mammals, including humans, respond to injury by releasing endogenous opioids—compounds that mitigate acute pain. A team of researchers led by those at the University of Kentucky has uncovered groundbreaking ...
Right combination of sugars regulates brain development in worms
Sep 19, 2013
If the development of our nervous system is disturbed, we risk developing serious neurological diseases, impairing our sensory systems, movement control or cognitive functions. This is true for all organisms ...
User comments
© Medical Xpress 2011-2013, Phys.org network
0 comments:
Post a Comment